Combined Cis-platinum and Alpha Interferon Therapy of Advanced Hepatocellular Carcinoma
Sang Keun Ji, Neung Hwa Park, Hyun Mook Choi, Young Woo Kim, Sin Hwa Lee, Keum Hee Lee, Su Yul Ahn, Sang Uk Lee, Byung Hoon Han, Byung Chae Park
Korean J Intern Med. 1996;11(1):58-68.   Published online 1996 Jan 1     DOI:
Citations to this article as recorded by Crossref logo
Chapter 4: Chemotherapy and radiotherapy
Hepatology Research.2010; 40: 74.     CrossRef
Future perspectives on the treatment of hepatocellular carcinoma with cisplatin
Toru Ishikawa
World Journal of Hepatology.2009; 1(1): 8.     CrossRef
Consensus and Controversy in the Management of Hepatocellular Carcinoma
Robin D. Kim, Alan I. Reed, Shiro Fujita, David P. Foley, Kristin L. Mekeel, Alan W. Hemming
Journal of the American College of Surgeons.2007; 205(1): 108.     CrossRef
Immunotherapy of hepatocellular carcinoma
Tim F. Greten, Michael P. Manns, Firouzeh Korangy
Journal of Hepatology.2006; 45(6): 868.     CrossRef
Systemic therapy for advanced hepatocellular carcinoma: a review
Anna K Nowak, Pierce K.H Chow, Michael Findlay
European Journal of Cancer.2004; 40(10): 1474.     CrossRef
Interferon for preventing and treating hepatocellular carcinoma associated with the hepatitis B and C viruses
E. Tabor
Digestive and Liver Disease.2003; 35(5): 297.     CrossRef
Non-Surgical Treatment Options in Hepatocellular Carcinoma
Sanjay M. Kariappa, Matthew Links, David L. Morris
Cancer Reviews: Asia-Pacific.2003; 01(02): 245.     CrossRef
Remission and Survival Following Monthly Intraarterial Cisplatinum in Nonresectable Hepatoma
Wayne S. Court, Stanley E. Order, Jeffry A. Siegel, Elizabeth Johnson, Albert S. DeNittis, Robert Principato, Karen Martz, Louis S. Zeiger
Cancer Investigation.2002; 20(5-6): 613.     CrossRef
A Phase II trial of nolatrexed dihydrochloride in patients with advanced hepatocellular carcinoma
Keith Stuart, Judy Tessitore, Jeff Rudy, Neil Clendennin, Amanda Johnston
Cancer.1999; 86(3): 410.     CrossRef